Sofinnova Ventures »

Novo Nordisk A/S shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $79M 612k 128.40
2022-06-30 $31M 274k 111.43
2019-06-30 $17M 324k 51.04
2019-03-31 $13M 248k 52.31

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Aerovate Therapeutics (AVTE)
Merck & Co (MRK)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Novo-Nordisk A S Adr (NVO)
Incyte Corporation (INCY)
Argenx SE Sponsored Adr (ARGX)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Inhibrx (INBX)
Elanco Animal Health (ELAN)
IDEXX Laboratories (IDXX)
AstraZeneca Sponsored Adr (AZN)

View all positions for Sofinnova Ventures

Top funds holding Novo Nordisk A/S

Jennison Associates
FMR
Fisher Investments
Bank of America Corporation
Morgan Stanley
Fayez Sarofim & Co
Loomis, Sayles and
Folketrygdfondet
T. Rowe Price Associates
Polen Capital Management
BlackRock
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Jpmorgan Chase & Co
Royal Bank of Canada

View all funds holding Novo Nordisk A/S